US Stock MarketDetailed Quotes

ACTU Actuate Therapeutics

Watchlist
  • 8.620
  • +0.330+3.98%
Close Dec 13 16:00 ET
168.36MMarket Cap-5.92P/E (TTM)

About Actuate Therapeutics Company

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.

Company Profile

SymbolACTU
Company NameActuate Therapeutics
Listing DateAug 13, 2024
Issue Price8.00
Founded2015
CEOMr. Daniel M. Schmitt
MarketNASDAQ
Employees10
Fiscal Year Ends12-31
Address1751 River Run,Suite 400
CityFort Worth
ProvinceTexas
CountryUnited States of America
Zip Code76107
Phone1-817-887-8455
Websitehttp://www.actuatetherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Daniel M. Schmitt
  • President, Chief Executive Officer and Director
  • 520.00K
  • Paul J. Lytle
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Andrew P. Mazar, PhD
  • Chief Operating Officer
  • 666.11K
  • Dr. Aaron G.L. Fletcher, PhD
  • Chairman of the Board
  • 23.29K
  • Amy L. Ronneberg
  • Independent Director
  • --
  • Jason A. Keyes
  • Independent Director
  • --
  • Dr. Roger Sawhney
  • Independent Director
  • --
  • Dr. Dan Zabrowski, PhD
  • Independent Director
  • 23.29K
  • Todd S. Thon
  • Independent Director
  • 23.29K
  • Leslie W. Kreis, Jr
  • Independent Director
  • 23.29K
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Recent IPOs
Recent IPOs
Intraday-0.76%